Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

Florian Huemer; Martin Dejaco; Christoph Grabmer; Thomas Melchardt; Daniel Neureiter; Georg Mayer; Alexander Egle; Richard Greil; Lukas Weiss

doi:10.1007/s00508-016-1124-4

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

Florian Huemer (Erstautor/-in), Martin Dejaco, Christoph Grabmer (Co-Autor/-in), Thomas Melchardt (Co-Autor/-in), Daniel Neureiter^* (Co-Autor/-in), Georg Mayer, Alexander Egle (Co-Autor/-in), Richard Greil (Co-Autor/-in), Lukas Weiss (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	144
Fachzeitschrift	WIENER KLINISCHE WOCHENSCHRIFT
Jahrgang	129
Ausgabenummer	3-4
DOIs	https://doi.org/10.1007/s00508-016-1124-4
Publikationsstatus	Veröffentlicht - 2017

Zugriff auf Dokument

10.1007/s00508-016-1124-4

Dieses zitieren

@article{cc81f6837e5e4918b052ec200afe8e76,

title = "Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.",

keywords = "EPISTAXIS, GENE",

author = "Florian Huemer and Martin Dejaco and Christoph Grabmer and Thomas Melchardt and Daniel Neureiter and Georg Mayer and Alexander Egle and Richard Greil and Lukas Weiss",

note = "Huemer, Melchardt, Egle, Greil, Weiss: IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumathology, Oncologic Center, Paracelsus Medical University, Muellner Hauptstra{\ss}e 48, 5020 Salzburg, Austria; Dejaco: Department of Otorhinolaryngology, Paracelsus Medical University, Salzburg, Austria; Grabmer, Mayer: Blood Group Serology and Transfusion Medicine, Paracelsus Medical University, Salzburg, Austria; Neureiter: Institute of Pathology, Paracelsus Medical University, Salzburg, Austria",

year = "2017",

doi = "10.1007/s00508-016-1124-4",

language = "English",

volume = "129",

pages = "144",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "3-4",

}

TY - JOUR

T1 - Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

AU - Huemer, Florian

AU - Dejaco, Martin

AU - Grabmer, Christoph

AU - Melchardt, Thomas

AU - Neureiter, Daniel

AU - Mayer, Georg

AU - Egle, Alexander

AU - Greil, Richard

AU - Weiss, Lukas

N1 - Huemer, Melchardt, Egle, Greil, Weiss: IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumathology, Oncologic Center, Paracelsus Medical University, Muellner Hauptstraße 48, 5020 Salzburg, Austria; Dejaco: Department of Otorhinolaryngology, Paracelsus Medical University, Salzburg, Austria; Grabmer, Mayer: Blood Group Serology and Transfusion Medicine, Paracelsus Medical University, Salzburg, Austria; Neureiter: Institute of Pathology, Paracelsus Medical University, Salzburg, Austria

PY - 2017

Y1 - 2017

KW - EPISTAXIS

KW - GENE

U2 - 10.1007/s00508-016-1124-4

DO - 10.1007/s00508-016-1124-4

M3 - Case report

C2 - 27878613

SN - 0043-5325

VL - 129

SP - 144

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - 3-4

ER -